Testosterone levels are dropping, while chronic disease and suicide rates are climbing. Here's what federal health officials ...

A new Oregon study shows that pediatric gender transitions aren’t as rare as advocates of the “affirming” model assured us.

Crinetics Pharmaceuticals stock is a 'Buy' rating due to EU approval and strong initial U.S. uptake of Palsonify for ...

Androgen deprivation therapy (ADT) has long been the cornerstone of treatment for advanced prostate cancer. Since ...

Compounded drugs sold for cash prices don’t generate billing records that would allow regulators to track basic information, ...

Marius Pharmaceuticals has backed a move by the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to update prescribing information for testosterone ...

One afternoon in late 2024, a sixth-grader nicknamed Bug came home from school with an announcement to make. Bug, who was assigned female at birth, told his parents he was a boy — and would be using ...

The U.S. Food and Drug Administration (FDA) is asking drugmakers to update the prescribing information on testosterone ...

Younger Americans are falling behind on cancer screenings, testosterone therapy warnings may soon change and a rare amoeba ...

Learn how Oestra uses vaginal hormone delivery to support systemic hormone therapy with a simplified daily approach.

A follow-up of the T4DM trial in men with prediabetes or recent-onset type 2 diabetes show no further glycemic improvement ...

Multiple experts who reviewed the donation say the payment could qualify as a conflict because it has the potential to ...